Addressing an urgent need arising from the SARS-CoV-2 coronavirus outbreak and the COVID-19 disease that can result from it, Boston Scientific (NYSE:BSX) is manufacturing a new, relatively inexpensive "ventilator alternative." This product, which is to be branded under the name Coventor, received Food and Drug Administration (FDA) Emergency Use Authorization approval last Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,